Peg-IFNPeg-interferonhepatitis BHBV
…d 16.3% at 48 weeks of peg-IFN therapy, respectively.Conclusion Peg-IFN add-on results in HBsAg loss in 18% of patients with SOT HBsAg<…
4articles mentioning drugs
17drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: Peg-IFN ×
Peg-IFN
This drug is selected. Its supporting articles are shown below.
Articles mentioning Peg-IFN
4 articles · page 1 of 1peg-IFNchronic hepatitis BBioProject PRJNA1096305HBsAg lossStudy SRP499879chronic hepatitis B (CHB)CHB
… may contribute to functional cure in CHB patients treated with peg-IFN. IRF4 may serve as a key regulator of T cell exhaustion and a p…
DOC1021DOC1021-relatedpeg-IFNPancreatic ductal adenocarcinoma (PDAC)Baylor College of MedicineFood and Drug AdministrationCancer Cures 4 KidsDiakonos Oncology CorporationWCG institutional review board
…s and peripheral blood T-cell responses are ongoing.Conclusions DOC1021 immunotherapy after surgical resection and standard neoadjuvant…
pegylated interferon alfaPEG-IFNHBsAg-lowering agentshepatocellular carcinomachronic hepatitis Bcirrhosisantiviral therapy
…NA therapy.1 The 2025 EASL guidelines accordingly still include pegylated interferon alfa (PEG-IFN) as an option for therapy in selected patients, given …